1 / 5

Epigenetics Market Size, Share, Scope, Growth and Forecast to 2029

The latest report by Precision Business Insights, titled u201cEpigenetics Marketu201d covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

shristis030
Télécharger la présentation

Epigenetics Market Size, Share, Scope, Growth and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epigenetics Market (2023-29)

  2. Market Overview: The global epigenetics market size was valued at US$ 823 Million in 2022 and is projected to reach US$ 2021.73 Million at a CAGR of 13.7% by 2029 during the forecast period 2023- 2029. The epigenetics market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of theepigenetics market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: The epigenetics market has been fragmented based on: 1. By Enzymes: DNA polymerase, Acetylases, DNA ligases, Methyltransferase, RNA ligases, Reverse Transcriptase, Others 2. By Instruments:Next generation sequencers, Mass spectrometers, Sonicators, qPCRs, Others 3. By Application: Oncology, Cardiovascular Diseases, Metabolic Diseases, Inflammatory Diseases, Infectious Diseases 4. By Kits and Assays: Deep sequencing kit, Bisulfate conversion kit, Methyltransferase assays, Chip- seq kits, Immunoprecipitation kits, Histone assay 5. By End-User: Pharmaceutical and biotechnological companies, Contract research companies, Academic and Research Institutes 6. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America. Request Sample Report

  4. Key Players: • Some of the major key players in the epigenetics market are: • Illumina, Inc. (U.S.) • Abcam plc. (U.K) • QIAGEN N.V. (Netherland) • New England Biolabs, Inc. (U.S.) • Merck & Co. (U.S.) • Sigma-Aldrich Corporation (U.S.) • Genedata AG(Switzerland) • Cayman chemical company (U.S) • Active Motif (U.S.) • Thermo Fisher Scientific, Inc., (U.S.) • Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related